Publication

Date Item Type Full Text Status

20 February 2026

AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study. (2026) Nikita Sushentsev, Zobair Arya, Jobie Budd, Amy Frary, Nadia Moreira da Silva, Mirjana Ferrer Rodriguez, Paul Burn, Richard Hindley, Nikhil Vasdev, Mohamed Ibrahim, Alison Bradley, Adrian Andreou, Sidath Liyanage, Raj Persad, Jonathan Aning, Alexander B C D Ng, Aqua Asif, Veeru Kasivisvanathan, Tristan Barrett, Mark Hinton, Anwar Roshanali Padhani, Aarti Shah, Lucy Davies, Antony Rix and Evis Sala

28 February 2025

AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study. (2025) Francesco Giganti, Nadia Moreira da Silva, Michael Yeung, Lucy Davies, Amy Frary, Mirjana Ferrer Rodriguez, Nikita Sushentsev, Nicholas Ashley, Adrian Andreou, Alison Bradley, Chris Wilson, Giles Maskell, Giorgio Brembilla, Iztok Caglic, Jakub Suchánek, Jobie Budd, Zobair Arya, Jonathan Aning, John Hayes, Mark De Bono, Nikhil Vasdev, Nimalan Sanmugalingam, Paul Burn, Raj Persad, Ramona Woitek, Richard Hindley, Sidath Liyanage, Sophie Squire, Tristan Barrett, Steffi Barwick, Mark Hinton, Anwar R. Padhani, Antony Rix, Aarti Shah and Evis Sala

13 July 2021

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance. (2021) Nikita Sushentsev, Leonardo Rundo, Oleg Blyuss, Tatiana Nazarenko, Aleksandr Suvorov, Vincent J. Gnanapragasam, Evis Sala and Tristan Barrett description

2010

Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. (2010) V. Goh, M. Shastry, A. Engledow, J. Reston, J. Peck, R. Endozo, M. Rodriguez-Justo, S.A. Taylor and S. Halligan

2009

Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis. (2009) V. Goh, B. Sanghera, D. Wellsted, J. Sundin and S. Halligan

Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. (2009) V. Goh, S. Halligan, D. Wellsted and C.I. Bartram

1 August 2003

Do CEC guidelines under-utilise the full potential of increasing kVp as a dose-reducing tool? (2003) P. Doherty, D. O'Leary and Patrick C. Brennan